pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
seltorexant
Insomnia
Orexin receptor type 2
$JNJ
JOHNSON & JOHNSON
0
catalysts
Preclinical
semaglutide
Obesity
BioLingus AG
0
catalysts
Phase 2
semzuvolimab
semzuvolimab [INN]
Human Immunodeficiency Virus (HIV) Infections (AIDS)
United BioPharma Inc
0
catalysts
← prev
page 255 of 271
next →
131
Pain
89
Neurology
1
Phase 2
sepantronium bromide
Burkitt Lymphoma
Beijing zhikangbo Medical Oncology Research Co Ltd
0
catalysts
Phase 2
sepetaprost
sepetaprost [INN]
Ocular Hypertension
Santen Pharmaceutical Co Ltd
0
catalysts
Marketed
sepiapterin
Sephience (sepiapterin)
Hyperphenylalaninemia
$PTC
PTC INC.
0
catalysts
Phase 3
seralutinib
Pulmonary Arterial Hypertension
Platelet-derived growth factor receptor
Macrophage colony-stimulating factor 1 receptor
$GOSS
Gossamer Bio, Inc.
0
catalysts
Marketed
sertaconazole nitrate
Ertaczo (sertaconazole nitrate)
Tinea Pedis (Athlete Foot)
Bausch Health Americas Inc
0
catalysts
Phase 2
setanaxib
setanaxib [INN]
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Calliditas Therapeutics AB
0
catalysts
Phase 3
setrusumab
Osteogenesis Imperfecta
Sclerostin
$RARE
Ultragenyx Pharmaceutical Inc.
0
catalysts
Phase 3
sevasemten
Becker Muscular Dystrophy
$EWTX
Edgewise Therapeutics, Inc.
0
catalysts
Marketed
sevelamer hydrochloride
Sevelamer Hydrochloride Winthrop (sevelamer hydrochloride)
Hyperphosphatemia In Chronic Kidney Disease
Winthrop US
0
catalysts
Phase 2
seviprotimut-L
Melanoma
Polynoma LLC
0
catalysts
Marketed
short ragweed pollen (Ambrosia artemisiifolia) allergen extract ODT
Ragwitek
Ragweed Pollen Allergy
ALK-Abello Inc
0
catalysts
Phase 2
siG-12D-LODER
Pancreatic Ductal Adenocarcinoma
$SLXN
Silexion Therapeutics Corp
0
catalysts
Phase 2
sildenafil citrate
Hezkue (sildenafil citrate)
Female Hypoactive Sexual Desire Disorder
cGMP-specific 3',5'-cyclic phosphodiesterase
$DARE
Dare Bioscience, Inc.
0
catalysts
Preclinical
sildenafil citrate SR
sildenafil citrate
Erectile Dysfunction
Atticus Pharma Inc
0
catalysts
Phase 2
silevertinib
Non-Small Cell Lung Cancer
$BDTX
Black Diamond Therapeutics, Inc.
0
catalysts
Phase 2
silmitasertib
silmitasertib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Senhwa Biosciences Inc
0
catalysts
Marketed
silodosin
Silodosin (silodosin [INN])
Storage Symptoms of Benign Prostatic Hyperplasia
Creekwood Pharmaceutical Inc
0
catalysts
Marketed
siltuximab
Sylvant (siltuximab)
Giant Lymph Node Hyperplasia (Castleman's Disease)
Recordati Corp
0
catalysts
Marketed
silver sulfadiazine
Thermazene (silver sulfadiazine)
Bacterial Sepsis
Mallinckrodt LLC
0
catalysts
Phase 3
simoladagene autotemcel
Adenosine Deaminase (ADA) Deficiency Related SCID
Rarity PBC
0
catalysts
Marketed
sinecatechins
Veregen (sinecatechins)
Genital Warts (Condylomata Acuminata)
$ANIP
ANI PHARMACEUTICALS INC
0
catalysts
Phase 2
sintilimab
Angiosarcoma
Programmed cell death protein 1
Innovent Biologics Inc
0
catalysts
Marketed
siponimod fumarate
Mayzent (siponimod fumarate)
Relapsing Remitting Multiple Sclerosis (RRMS)
$NVS
NOVARTIS AG
0
catalysts
Marketed
sipuleucel-T
Provenge (sipuleucel-T)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Dendreon Pharmaceuticals LLC
0
catalysts
Phase 1
siremadlin succinate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$NVS
NOVARTIS AG
0
catalysts
Phase 2
sirexatamab
sirexatamab [INN]
Endometrial Cancer
Leap Therapeutics Inc
0
catalysts
Phase 3
sirolimus
QTORIN rapamycin (sirolimus)
Lymphangioleiomyomatosis
Peptidyl-prolyl cis-trans isomerase FKBP1A
OrphAI Therapeutics Inc
0
catalysts
